First-line and second-line antiretroviral therapy - Author's reply

被引：0
|
作者：
Carr, A [1 ]
机构：
[1] St Vincents Hosp, Sydney, NSW 2010, Australia
来源：
LANCET | 2004年 / 364卷 / 9431期
关键词：
D O I：
10.1016/S0140-6736(04)16718-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [1] First-line and second-line antiretroviral therapy
    Calmy, A
    Pascual, F
    Ford, N
    LANCET, 2004, 364 (9431): : 329 - 329
  • [2] Association of First-Line and Second-Line Antiretroviral Therapy Adherence
    Ramadhani, Habib O.
    Thielman, John A. Bartlett Nathan M.
    Pence, BrianW.
    Kimani, Stephen M.
    Maro, Venance P.
    Mwako, Mtumwa S.
    Masaki, Lazaro J.
    Mmbando, Calvin E.
    Minja, Mary G.
    Lirhunde, Eileen S.
    Miller, William C.
    OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (02):
  • [3] Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
    Meloni, Seema T.
    Onwuamah, Chika K.
    Agbaji, Oche
    Chaplin, Beth
    Olaleye, David O.
    Audu, Rosemary
    Samuels, Jay
    Ezechi, Oliver
    Imade, Godwin
    Musa, Adesola Z.
    Odaibo, Georgina
    Okpokwu, Jonathan
    Rawizza, Holly
    Mu'azu, Muhammad A.
    Dalhatu, Ibrahim
    Ahmed, Mukhtar
    Okonkwo, Prosper
    Raizes, Elliot
    Ujah, Innocent A. O.
    Yang, Chunfu
    Idigbe, Emmanuel O.
    Kanki, Phyllis J.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (04):
  • [4] Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation
    Desmonde, Sophie
    Eboua, Francois T.
    Malateste, Karen
    Dicko, Fatoumata
    Ekouevi, Didier K.
    Ngbeche, Sylvie
    Koueta, Fla
    Sy, Haby Signate
    Renner, Lorna
    Koumakpai, Siriatou A.
    Leroy, Valeriane
    AIDS, 2015, 29 (12) : 1527 - 1536
  • [5] Resistance in Pediatric Patients Experiencing Virologic Failure With First-line and Second-line Antiretroviral Therapy
    Orrell, Catherine
    Levison, Julie
    Ciaranello, Andrea
    Bekker, Linda-Gail
    Kuritzkes, Daniel R.
    Freedberg, Kenneth A.
    Wood, Robin
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (06) : 644 - 647
  • [6] Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon
    Njom-Nlend, Anne-Esther
    Efouba, Nadege
    Brunelle Sandie, Arsene
    Fokam, Joseph
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 (08) : 927 - 935
  • [7] Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa
    Fox, Matthew P.
    Van Cutsem, Gilles
    Giddy, Janet
    Maskew, Mhairi
    Keiser, Olivia
    Prozesky, Hans
    Wood, Robin
    Hernan, Miguel A.
    Sterne, Jonathan A. C.
    Egger, Matthias
    Boulle, Andrew
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (04) : 428 - 437
  • [8] Evaluation of Namibia's antiretroviral therapy guidelines' recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study
    Kalemeera, F.
    Ndevahoma, St
    Mubita, M.
    Godman, Brian
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 915 - 921
  • [9] Methotrexate: first-line or second-line immunomodulator?
    Fraser, AG
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (03) : 225 - 231
  • [10] The Transition From First-Line to Second-Line Therapy in Multiple Sclerosis
    Jan Dörr
    Friedemann Paul
    Current Treatment Options in Neurology, 2015, 17
12345